Ironwood Pharma grants 137,036 RSUs to CMO
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Silber Jeffrey reported acquisition or exercise transactions in this Form 4 filing.
Ironwood Pharmaceuticals Inc granted its SVP, CMO and Head of Research & Drug Development, Jeffrey Silber, a new-hire restricted stock unit award covering 137,036 shares of Class A Common Stock. The award vests 25% of the shares on each approximate anniversary of the grant, resulting in direct ownership of 137,036 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock F1 | 137,036 | $0.00 | $0.00 |
Footnotes (1)
- F1. The restricted stock unit award, granted as a new hire award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
Key Figures
Key Terms
restricted stock unit financial
new hire award financial
Class A Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity award did Jeffrey Silber receive from IRWD?
How do the restricted stock units granted by IRWD to Jeffrey Silber vest?
Was Jeffrey Silber’s IRWD equity grant made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.